InQueensland

NEWS •⁠ POLITICS •⁠ BUSINESS •⁠ CULTURE

Get InQueensland in your inbox Subscribe

This is the new face of deadly Delta outbreak - could Astra vaccine have saved her?

News

AstraZeneca has come out in defence of its vaccine for all adults after Australia’s national medical panel again changed its advice for people in Sydney, where the latest Delta virus victim has been identified.

Print article

The city’s continuing COVID-19 crisis means the Australian Technical Advisory Group on Immunisation has strongly recommended every adult in Sydney get whatever jab they can, including AstraZeneca.

An accounting student in her 30s has been remembered as “hardworking” and “an amazing friend” after her death from COVID-19.

The ABC identified her as Adriana Midori Takara, 38, who had no underlying health conditions. However the Brazilian national’s condition deteriorated quickly after contracting the Delta strain.

She died in the early hours of Sunday at Royal Prince Alfred Hospital in Sydney’s inner west, about 10 days after contracting the virus.

Marlene Coimbra, who runs a migration consultancy and helped Takara secure a student visa and a place at Sydney’s Kaplan Business School said her former student, her boyfriend and a flatmate tested positive to the virus.

Coimbra said she was shocked the virus ravaged Takara’s her body “so quickly”.

“When they had the first test, Adriana was negative and her boyfriend was positive,” she said.

Takara’s boyfriend and flatmate, a nurse, were immediately isolated.

“A few days later, Adriana had the second test and … she was positive,” Coimbra told the ABC.

“Just so quickly. So quickly, you know, how her body disintegrated. It’s just terrible.”

AstraZeneca says the advice of ATAGI and Therapeutic Goods Administration reinforced decisions by global authorities, particularly for protection against the Delta variant.

“Regulatory authorities around the world have stated that the benefit of using our vaccine significantly outweigh the risks across all adult age groups,” the company said in a statement on Monday.

More than 750 million doses of AstraZeneca have been supplied to more than 170 countries in the past year.

“Our vaccine continues to be an important tool in overcoming the COVID-19 global health emergency, underpinned by our commitment to provide broad and equitable access, at no profit during the pandemic.”

Prime Minister Scott Morrison has promised an extra 90,000 Pfizer doses for NSW following lobbying from the premier.

Pfizer remains the preferred vaccine for under-60s, but any adult can go to a doctor and seek an AstraZeneca jab if they provide informed consent.

Australia has also secured another 85 million Pfizer doses to cover booster shots in 2022 and 2023.

Eight people, including a woman aged in her 30s, have died in the outbreak as NSW reported 141 new cases on Sunday.

Immunologist Peter Doherty said the Delta variant had led to more severe disease in younger people.

“A lot of young people thought for a long time that they kind of had a free pass with this,” he told ABC radio.

People have a much greater risk of becoming severely ill or dying from the virus than the AstraZeneca vaccine.

President of the Australian Medical Association in New South Wales Danielle McMullen said Ms Takara’s death was a grim reminder for young people.

Only about six of the more than 900 deaths in Australia from COVID have been people under 49.

But McMullen said as more people aged over 60 were getting vaccinated, the outbreak underway in Sydney was affecting the younger population.

It also prompted NSW Premier Gladys Berejiklian to warn young people could fall victim to the “cruel disease”.

“If anybody thinks this is a disease just affecting older people, please think again,” she said on Sunday.

Deputy Prime Minister Barnaby Joyce said Sydney’s outbreak was “not as in control as we would want but it’s certainly not out of control”.

The city’s lockdown is due to end on July 30 but is highly likely to be extended.

Opposition Leader Anthony Albanese said ATAGI’s latest advice was not a major departure from its earlier recommendations.

“There’s not a big change between what they did say previously, which was that people could get the vaccine to AstraZeneca if they consulted with their doctor,” Mr Albanese said.

“And now they say, because the risk assessment has changed, they’ve made a slight adjustment to that advice.”

The ATAGI advice on AstraZeneca balances the risk of developing rare blood clots against the benefits of protection against coronavirus.

More News stories

Loading next article